Golden State Medical Supply, Inc. was awarded a single-award indefinite delivery contract by the Department of Veterans Affairs National Acquisition Center to provide Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg tablets. The contract has a potential value of $3,599,069.90 over a one year base period and four one-year option periods, running from April 2024 to April 2025.
Under the contract, Golden State Medical Supply will distribute pharmaceutical products through the VA's Pharmaceutical Prime Vendor program to VA hospitals, Department of Defense medical treatment facilities, Bureau of Prisons prisons, and Indian Health Service centers. Specifically, the original pre-solicitation notice indicated the VA's estimated annual requirement is 102,123 bottles of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg tablets, to treat veterans and other agency patients. As the single awardee, Golden State Medical Supply will utilize its distribution infrastructure to deliver the contracted medications and medical supplies on an as-needed basis through ordering periods against the indefinite delivery contract.
Generated 2/29/24, 9:19 AM